These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37861550)

  • 1. Role of TOP2A and CDC6 in liver cancer.
    Jia W; Liu X; Zhang Z
    Medicine (Baltimore); 2023 Oct; 102(42):e35604. PubMed ID: 37861550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RRP9 and DDX21 as new biomarkers of colorectal cancer.
    Chi X; Yang N; Liu Y
    Medicine (Baltimore); 2023 Oct; 102(43):e34384. PubMed ID: 37904456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK1 and CCNA2 play important roles in oral squamous cell carcinoma.
    Zhang J; Di Y; Zhang B; Li T; Li D; Zhang H
    Medicine (Baltimore); 2024 Apr; 103(16):e37831. PubMed ID: 38640322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high expression of TOP2A and MELK induces the occurrence of psoriasis.
    Zhu X; Zhang E; Qin L
    Aging (Albany NY); 2024 Feb; 16(4):3185-3199. PubMed ID: 38382096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.
    Wu M; Liu Z; Zhang A; Li N
    Medicine (Baltimore); 2019 Feb; 98(5):e14287. PubMed ID: 30702595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
    Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
    Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
    Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
    Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
    He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
    Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAV1 and KRT5 are potential targets for prostate cancer.
    Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
    Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KNTC1 and MCM2 are the molecular targets of gallbladder cancer.
    Jia W; Wang C
    Aging (Albany NY); 2023 Jul; 15(14):7008-7022. PubMed ID: 37480569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of the miRNA-mRNA regulatory network and analysis of hub genes in oral squamous cell carcinoma.
    Cui Z; Song Q; Chen Y; Yang K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Sep; 166(3):280-289. PubMed ID: 35132271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients.
    Zhuang L; Yang Z; Meng Z
    Biomed Res Int; 2018; 2018():7897346. PubMed ID: 30363964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang WX; Pan YY; You CG
    Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of potential key genes in very early hepatocellular carcinoma.
    Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
    World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring Potential Biomarkers, Ferroptosis Mechanisms, and Therapeutic Targets Associated with Cutaneous Squamous Cell Carcinoma via Integrated Transcriptomic Analysis.
    Su W; Huang B; Zhang Q; Han W; An L; Guan Y; Ji J; Yu D
    J Healthc Eng; 2022; 2022():3524022. PubMed ID: 36247089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.